Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 24-week, multicenter, multinational, randomized, double-blind, triple-dummy, 3-arm parallel group study comparing the efficacy and safety of CHF 1535 200/6 (beclomethasone dipropionate 200 microg plus formoterol 6 microg/actuation), 2 puffs b.i.d., versus beclomethasone diproprionate HFA (250 microg/actuation), 4 puffs b.i.d., versus Seretide 500/50 (fluticasone 500 microg plus salmeterol 50 microg/actuation), 1 inhalation b.i.d., in patients with severe asthma

Next Previous
Trial Profile

A 24-week, multicenter, multinational, randomized, double-blind, triple-dummy, 3-arm parallel group study comparing the efficacy and safety of CHF 1535 200/6 (beclomethasone dipropionate 200 microg plus formoterol 6 microg/actuation), 2 puffs b.i.d., versus beclomethasone diproprionate HFA (250 microg/actuation), 4 puffs b.i.d., versus Seretide 500/50 (fluticasone 500 microg plus salmeterol 50 microg/actuation), 1 inhalation b.i.d., in patients with severe asthma

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Beclometasone/formoterol (Primary) ; Beclometasone; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Chiesi Farmaceutici

Most Recent Events

  • 03 Jul 2012 Additional trial location (Czech Republic) added as reported by European Clinical Trials Database record.
  • 03 Jul 2012 Actual end date (10 Sep 2009) added as reported by European Clinical Trials Database record.
  • 24 Aug 2011 Planned End Date changed to 14 Mar 2009.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top